Demyelinating disease: Phase III trials

A Double Blind Trial To Evaluate The Safety And Efficacy Of Eculizumab In Relapsing NMO Patients (PREVENT Study)

Eculizumab

Phase III

Multiple worldwide locations

Recruiting

Click here for further information


A Multicentre randomiSed Controlled TRial of IntraVEnous Immunoglobulin Versus Standard Therapy for Transverse Myelitis (STRIVE)

Intravenous Methylprednisolone, Intravenous Immunoglobulin

Phase III

United Kingdom

Recruiting

Click here for further information